Product Information
CARAFATE 1 GM/10 ML SUSP is a brand product labeled by Allergan, Inc., priced at $0.6104 per ML under NDC 58914017014. Its NADAC has been published 626 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Sucralfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 g/10mL
Manufacturer
Allergan, Inc.NDC
58914017014
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
7/23/2025
Active Ingredients
SUCRALFATEApproval Type
New Drug (NDA)
FDA Application
NDA019183On Market Since
12/16/1993
Pharmacological Classes
Price Statistics
The NADAC for CARAFATE 1 GM/10 ML SUSP has been published 626 times since Nov 28, 2013, and over the history we have for it it has risen 155.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6104 per ML |
|---|---|
| All-time high | $0.6111 (Jul 16, 2025) |
| All-time low | $0.2392 (Nov 28, 2013) |
| 52-week high | $0.6111 |
| 52-week low | $0.6104 |
| Median price | $0.4849 |
| Average price | $0.4690 |
| Largest weekly change | +15.0% (Jul 8, 2015) |
| Weeks tracked | 626 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARAFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CARAFATE 1 GM/10 ML SUSP, manufactured by Allergan, Inc., is $0.6104 per ML (NDC 58914017014), effective Nov 19, 2025.
How has the price of CARAFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for CARAFATE 1 GM/10 ML SUSP has risen 155.2%. It has been tracked across 626 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARAFATE 1 GM/10 ML SUSP?
Since Nov 28, 2013, the NADAC for CARAFATE 1 GM/10 ML SUSP has ranged from a low of $0.2392 (Nov 28, 2013) to a high of $0.6111 (Jul 16, 2025), with a median of $0.4849 per ML.
Are there cheaper alternatives to CARAFATE 1 GM/10 ML SUSP?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SUCRALFATE 1 GM/10 ML SUSP, is $0.1144 per ML — about 81% below CARAFATE 1 GM/10 ML SUSP.
Who manufactures CARAFATE 1 GM/10 ML SUSP?
CARAFATE 1 GM/10 ML SUSP (NDC 58914017014) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification